🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc. logo
Market Cap: Medium
Employees: Lowest

CTI-1601

Larimar Therapeutics, Inc. is a clinical-stage biotechnology company developing treatments for rare diseases using a novel cell penetrating peptide technology platform. Their lead product candidate, CTI-1601, is undergoing Phase 1 clinical trials to treat Friedreich's ataxia.

Tags: Friedreich's ataxia, biotechnology, cell penetrating peptide, clinical-stage, novel technologies, rare diseases

Website

About | Leadership | Directors | About | Contact | Contact | Careers | Careers | About | About | About | Careers

Symbol: LRMR

Recent Price: $3.91

Industry: Biotechnology

CEO: Dr. Carole S. Ben-Maimon M.D.

Sector: Healthcare

Employees: 42

Address: Three Bala Plaza East, Bala Cynwyd, PA 19004

Phone: 844 511 9056

Leadership

  • Carole Ben-Maimon, MD, President and Chief Executive Officer
  • Gopi Shankar, PhD, MBA, FAAPS, Chief Development Officer
  • Rusty Clayton, DO, Chief Medical Officer
  • Michael Celano, CHIEF FINANCIAL OFFICER
  • John Berman, Vice President of Finance and Administration
  • Jennifer Johansson, Vice President, Legal and Compliance
  • Keith E. Lynch, Jr., Vice President, CMC Technical Operations
  • Noreen Scherer, Vice President of Clinical Operations
  • Francis Michael Conway, CPA, VICE PRESIDENT AND CONTROLLER
  • Mohamed Hamdani, Vice President, Statistics and Quantitative Sciences
  • Adrienne Clements-Egan, Ph.D., Vice President, Bioanalytics and Developability
  • Frank Nazzario, RPh, Vice President, Commercial
  • Joseph Truitt, BOARD CHAIR
  • Tom Hamilton,
  • Jonathan Leff,
  • Frank E. Thomas,
  • Jeffrey Sherman, MD,
  • ,

Last updated: 2024-12-31